Cipla-Novartis patent row: DIPP looking into merit of case
The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access.
Nov 02, 2014, 11:51 AM IST
NPPA slaps Rs 300-crore penalty on Novartis for overcharging
Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.
Oct 13, 2014, 23:00 PM IST
GSKCH picks Zubair Ahmed for global role in JV with Novartis
The company said it would make a separate announcement of the organisational structure under Ahmed.
Oct 08, 2014, 14:37 PM IST
EU clears Novartis plan to sell animal health to Eli Lilly
EU regulators cleared on Friday the proposed sale of the animal health business of Swiss pharmaceutical giant Novartis to US group Eli Lilly, saying it would not violate competition rules.
Oct 03, 2014, 17:44 PM IST
Novartis cites momentum in 3% profit rise
Novartis is selling its animal health division to Eli Lilly for about USD 5.4 billion, in a deal it said on Thursday is now expected to close in the first quarter of 2015.
Jul 17, 2014, 15:10 PM IST
Novartis Japan unit charged over research manipulation
In April, Novartis replaced the top executives at its Japanese arm over those allegations.
Jul 01, 2014, 15:16 PM IST
Ranbaxy gets FDA approval for Novartis' Diovan generic
Ranbaxy will be the first rival drugmaker to launch a copy of Diovan in the United States and will be entitled to six months of exclusivity to sell it.
Jun 27, 2014, 09:39 AM IST
